Literature DB >> 3283596

New stereotactic technique for percutaneous thermocoagulation upper thoracic ganglionectomy in cases of palmar hyperhidrosis.

K S Chuang1, N H Liou, J C Liu.   

Abstract

To perform unilateral or bilateral upper thoracic ganglionectomy, we established a three-dimensional system of coordinates for T2 and T3 ganglia. For this purpose, the spatial relations were represented by drawings obtained from 50 Chinese cadavers. A simple stereotactic frame was constructed as an aid in performing the procedure. Then, according to the established three-dimensional system of coordinates, percutaneous thermocoagulation of both T2 and T3 ganglia was performed on 10 patients (20 sides) with palmar hyperhidrosis, under local anesthesia and fluoroscopic guidance at the posteroanterior projection. Excellent relief of abnormal sweating in 19 of the 20 hands was achieved. Partial relief was obtained in the remaining hand. No complication was observed in our patients. The technique has been proved to be safe, effective, and simpler than other methods now in use.

Entities:  

Mesh:

Year:  1988        PMID: 3283596     DOI: 10.1227/00006123-198803000-00031

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

1.  Efficacy of thoracic sympathetic ganglion block and prediction of complications: clinical evaluation of the anterior paratracheal and posterior paravertebral approaches in 234 patients.

Authors:  K Ohseto
Journal:  J Anesth       Date:  1992-07       Impact factor: 2.078

2.  Alteration in cardiovascular function and body surface temperature during percutaneous stereotactic upper thoracic ganglionectomy and sympathectomy in palmar hyperhidrotic patients.

Authors:  King-Shun Chuang; Wan-Cherng Liu; Jiang-Chuan Liu
Journal:  Clin Auton Res       Date:  2004-08       Impact factor: 4.435

Review 3.  The treatment of primary palmar hyperhidrosis: a review.

Authors:  M Hashmonai; D Kopelman; A Assalia
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.